Navigation Links
Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
Date:7/2/2012

EAST BRUNSWICK, N.J., July 2, 2012 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced a new publication showing that adult patients with refractory chronic gout (RCG) treated bi-weekly with KRYSTEXXA (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain and physical function. The article confirms that chronic gout, especially refractory chronic gout, is associated with decline in HRQOL and physical functioning compared to patients without chronic gout. The results were published in the print edition of the July 2012 issue of The Journal of Rheumatology.

"The significant improvements we observed in KRYSTEXXA-treated patients' pain, physical function and health-related quality of life are important as the daily burden of untreated RCG can be tremendous for these patients," said Vibeke Strand, M.D., Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine. "These improvements in quality of life measures also translate into meaningful savings in terms of cumulative treatment costs for patients with RCG."

The pre-specified, pooled analysis evaluated patient-reported outcomes from two replicate, randomized, double-blind, placebo-controlled Phase III studies of patients receiving treatment with KRYSTEXXA 8 mg every two weeks or every four weeks compared to placebo. At weeks one (baseline), 13, 19 and 25, investigators measured patient-reported HRQOL outcomes through four widely utilized assessment tools, namely, Medical Outcomes Study Short Form-36 (SF-36) physical component summary scores, the Health Assessment Questionnaire-Disability Index (HAQ-DI), patient global assessment of disease activity (PtGA) and pain by visual analog scale (VAS).

Results at week 25 demonstrated that mean improvements from baseline were statistically significant and exceeded minimum clinically important differen
'/>"/>

Contact: Mary Coleman
information@savient.com
732-418‑9300
Savient Pharmaceuticals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Genome-wide analysis shows previously undetected abnormalities in parents of affected children
2. Analysis will examine safety of in-hospital underwater births
3. Biochip-based device for cell analysis
4. Zinc Pills May Shorten Colds, Analysis Suggests
5. Analysis Finds Clinical Trials Often Small, of Poor Quality
6. SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples
7. Lung Cancer Screening Might Pay Off, Analysis Shows
8. Reach2HD, a Phase II study in Huntingtons disease, launched
9. ALS patients differ on treatment choices in later phases of disease
10. Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
11. Automated insulin dosage titration system demonstrates positive clinical study results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... When the mercury rises, heat can strain the limits ... takes on a heavier load in hot weather to keep ... the Harvard Men's Health Watch . , For otherwise ... knowing their limits and drinking enough fluids. But what about ... sensitive to the heat," says Dr. Joanne Foody, Director of ...
(Date:7/11/2014)... 11, 2014 Los Angeles dental ... he uses mini and full mouth implants to replace ... feature that distinguishes dental implants from other tooth replacements: ... the crowns. This alone prevents the long-term complications of ... advantages related to comfort, appearance and systemic health. Mini ...
(Date:7/11/2014)... A new study challenges the widely held belief that light ... Researchers analyzed more than 50 studies that examined drinking habits ... found that those with a form of a gene tied ... gene affects how a person,s body breaks down alcohol, resulting ... this variant has been shown to lead to lower drinking ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Cancer researchers ... have a significant impact on how patients respond to ... for mesothelioma. Surviving Mesothelioma has the full story. ... , Researchers at the University of Ljubljana and the ... pemetrexed for different types of polymorphisms. They found ...
(Date:7/11/2014)... 11, 2014 Anterior Cruciate Ligament (ACL) ... the type of material used to create a new ... game, say researchers presenting their work today at the ... Medicine ( AOSSM ). , “Our study ... (tissue harvested from a donor) fail more frequently than ...
Breaking Medicine News(10 mins):Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 2Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 3Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:ACL Reconstructions May Last Longer With Autografts 2
... disorders in this country has nearly doubled in the past ... psychologists and therapists are charged with the task, but many ... date and lack scientific rigor. This is in part because ... programs and for-profit training centersare not grounded in science. ...
... today for excellence in research, advancing oral health ... receive the 2009 American Dental Association,s (ADA) Gold Medal Award ... presentation during a meeting of the ADA,s House of ... every three years, the award honors individuals who contribute to ...
... Beginning October 1st, The Peninsula Chicago will dedicate itself to ... several cancer research and education organizations. , "We all know ... some way and this is why we at The Peninsula ... manager of The Peninsula Chicago. "In addition to the initiatives ...
... the largest non-government, not-for-profit funding source of cancer research ... research and training grants totaling $45,097,000 to 61 institutions ... 2009. The grants go into effect beginning January 1, ... Cancer Society has funded research and training of health ...
... ... Medical Center,s Emergency Department will begin using a new procedure, called therapeutic hypothermia, to ... , ... 2009 -- On October 19, 2009, Baptist Medical Center,s Emergency Department will ...
... Organization Exclusively for LTC Consumers Receives ... (formerly the National Citizens, Coalition for Nursing Home Reform) announced ... will help strengthen the organization,s role as a voice for ... organization exclusively for residents and their families and is a ...
Cached Medicine News:Health News:Where's the science? The sorry state of psychotherapy 2Health News:ADA's 2009 Gold Medal Award Presentation Set for 150th Annual Session 2Health News:The Peninsula Chicago Gives Back During Breast Cancer Awareness Month 2Health News:American Cancer Society awards 94 new research and training grants at 61 institutions nationwide 2Health News:American Cancer Society awards 94 new research and training grants at 61 institutions nationwide 3Health News:American Cancer Society awards 94 new research and training grants at 61 institutions nationwide 4Health News:American Cancer Society awards 94 new research and training grants at 61 institutions nationwide 5Health News:Baptist Using Therapeutic Hypothermia to Save Heart Attack Patients 2Health News:Long-Term Care Consumer Voices Strengthened 2
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, Inc. ... announced it has completed the sale to Galderma of ... owned or held by Valeant for $1.4 billion in ... S.A, which recently completed its acquisition of Galderma. ... of our products to a company that is firmly ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) ... quarterly dividend of $0.275 (27.5 cents) per share on the ... 2014, to holders of record on July 21, 2014. ... dedicated to helping people on their path to better health ... United States . Through the company,s more than 7,600 ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3
... Addressing the key clinical and economic issues ... System is designed to maximize tension control ... The system combines efficient instrumentation with a ... Grip system is indicated for general orthopaedic ...
... In 1985, the worlds first ... by Howmedica Osteonics as a means ... wire for trochanteric reattachment procedures. Today, ... papers demonstrating clinical successes, the Dall-Miles™ ...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery....
... have become the accepted standard for,excellence and ... AML Total Hip System was the first ... meet the needs for biological fixation in ... 15 years of documented clinical performance, the ...
Medicine Products: